Bionano Genomics Announces the Final Speaker Lineup for Symposium 2023 with 30 OGM Presentations and Live Panel Discussions Across a Wide Range of Genetic Disease and Cancer Research Applications
20 janv. 2023 08h00 HE
|
Bionano Genomics
27 different customers representing North America and Europe30 oral presentations across four consecutive days34 scientific posters will be featured in a virtual exhibition hallTopics span the...
Bionano Announces Publication of Interim Readout from Clinical Trial Run by Consortium Analyzing Optical Genome Mapping as Potential Standard of Care for Prenatal Testing
18 janv. 2023 08h00 HE
|
Bionano Genomics
IRB-approved, multi-site, ongoing study evaluated 200 samples representing 123 unique prenatal cases across 9 sites for interim measures of key endpoints: Results of OGM analysis were comparable, in...
Bionano to Accelerate Data Processing Solution for Optical Genome Mapping Workflow with NVIDIA
12 janv. 2023 08h00 HE
|
Bionano Genomics
SAN DIEGO, Jan. 12, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced a collaboration with NVIDIA to develop an acceleration platform for use in Bionano’s optical genome...
Bionano Announces Publication from Institut Curie Showing Utility of OGM for Detection of HRD in Breast Cancer
11 janv. 2023 08h00 HE
|
Bionano Genomics
SAN DIEGO, Jan. 11, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the publication of a study analyzing optical genome mapping (OGM) as a method to identify...
Bionano Genomics Announces 2023 Symposium: Four Consecutive Days of OGM Presentations and Live Panel Discussions Across a Wide Range of Genetic Disease and Cancer Applications
10 janv. 2023 08h00 HE
|
Bionano Genomics
SAN DIEGO, Jan. 10, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (BNGO) today announced its 2023 Symposium, which is the quintessential event for the optical genome mapping (OGM) community to...
Bionano Genomics to Host Strategy Day on February 2, 2023 in New York City
06 janv. 2023 08h00 HE
|
Bionano Genomics
SAN DIEGO, Jan. 06, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (BNGO) today announced that it will host its first-ever Strategy Day on Thursday, February 2nd, 2023, at the Nasdaq MarketSite in...
Bionano Genomics Reports Preliminary Fourth Quarter and Full-Year 2022 Results
05 janv. 2023 08h00 HE
|
Bionano Genomics
- Preliminary Q4 revenue expected to be between $8.1 and $8.4 million; 29% to 33% increase over Q4 2021- Reached installed base of 240 systems as of YE 2022; 46% increase over YE 2021- Achieved or...
Multi-Center Research Study Illustrates How OGM Can Potentially Result in More Patients Qualifying for Treatments in Leukemia
09 déc. 2022 08h00 HE
|
Bionano Genomics
Researchers from eight research institutes recommend OGM as first-line analysis for AML due to its ability to perform better and cost less than analysis with karyotyping, FISH, and CMAOGM identified...
Bionano Genomics Announces American Society of Hematology (ASH) Annual Meeting Presentations Featuring OGM Utility Across Blood Cancer Research Applications
08 déc. 2022 20h24 HE
|
Bionano Genomics
A scientific workshop will feature Dr. Rashmi Kanagal-Shamanna from the University of Texas MD Anderson Cancer Center delivering a presentation on the use of emerging technologies for prognostication...
Bionano Genomics to Acquire Purigen Biosystems to Enable Further Simplified and Accelerated DNA Isolation for Optical Genome Mapping (OGM) and Address Difficult Sample Types in New Applications with Isotachophoresis (ITP) on the Ionic Purification System
28 nov. 2022 17h00 HE
|
Bionano Genomics
Acquisition adds isotachophoresis (ITP), a proprietary technology licensed exclusively from Stanford University and developed by Purigen Biosystems for isolation and purification of nucleic acids, to...